SCHEMBL5435271

SCHEMBL5435271

CN(C)C(=O)Cn1c(-c2ccc(O)c(F)c2)c(C2CCCCC2)c2ccc(C(=O)O)cc21

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PRKCA P17252 1/20 0.42
MMP12 P39900 1/20 0.42
KDM4E B2RXH2 1/20 0.38
LMNA P02545 1/20 0.38
HSD17B10 Q99714 1/20 0.38
SCN9A Q15858 6/20 0.34
GRIN1 Q05586 1/20 0.34
GRIN2B Q13224 1/20 0.34
CCR3 P51677 2/20 0.33
CYP2D6 P10635 1/20 0.33
HRH1 P35367 1/20 0.33
KCNH2 Q12809 1/20 0.33
MAPT P10636 1/20 0.32
RARB P10826 1/20 0.32
RARG P13631 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
EGLN1 Q9GZT9 1/20 0.32
MIF P14174 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5434925 0.93 PRKCA (0.43) PRKCAMMP12SCN9AGRIN1GRIN2B
SCHEMBL5465729 0.90 PRKCA (0.39) PRKCAMMP12KDM4ELMNAHSD17B10
SCHEMBL5440051 0.89 PRKCA (0.44) PRKCAMMP12SCN9AGRIN2BCCR3
SCHEMBL5443976 0.88 PRKCA (0.45) PRKCAMMP12SCN9AMAPTL3MBTL1
SCHEMBL5437635 0.87 PRKCA (0.44) PRKCAMMP12SCN9AGRIN1GRIN2B
SCHEMBL5436038 0.87 PRKCA (0.44) PRKCAMMP12SCN9AGRIN2BCCR3
SCHEMBL5438990 0.86 PRKCA (0.45) PRKCAMMP12SCN9AMAPTL3MBTL1
SCHEMBL2907228 0.86 PRKCA (0.50) PRKCAMMP12SCN9ACYP2D6HRH1
SCHEMBL5442625 0.86 PRKCA (0.45) PRKCAMMP12SCN9AMAPT
SCHEMBL5433925 0.85 PRKCA (0.44) PRKCAMMP12SCN9ACYP2D6KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070167447-A1 Indole acetamides as inhibitors of the hepatitis c virus ns5b polymerase ISTITUTO DI RICERCHE DI BIOLOGIA DI MOLECULOARE P. ANGELETTI SPA (IT) 2007-07-19 US claimed
US-20070167447-A1 Indole acetamides as inhibitors of the hepatitis c virus ns5b polymerase ISTITUTO DI RICERCHE DI BIOLOGIA DI MOLECULOARE P. ANGELETTI SPA (IT) 2007-07-19 US disclosed
US-20070167447-A1 Indole acetamides as inhibitors of the hepatitis c virus ns5b polymerase ISTITUTO DI RICERCHE DI BIOLOGIA DI MOLECULOARE P. ANGELETTI SPA (IT) 2007-07-19 US disclosed
US-20070167447-A1 Indole acetamides as inhibitors of the hepatitis c virus ns5b polymerase ISTITUTO DI RICERCHE DI BIOLOGIA DI MOLECULOARE P. ANGELETTI SPA (IT) 2007-07-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070167447-A1 Indole acetamides as inhibitors of the hepatitis c virus ns5b polymerase IDO1, NAT1, AANAT PRKCA 4676/4885MMP12 3218/4885KDM4E 2022/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.